- Interactive Learning Program
Prescribing Information
Important Risk Information
References- Click each above to REVIEW or see below.
ASTEPRO 0.15% (azelastine HCl)—the Earlier the Better
Provides rapid relief as early as 30 to 45 minutes4,5*
Symptom relief right at the site
Treats nasal symptoms, including congestion, without an added decongestant2,3
Indicated for seasonal and perennial allergic rhinitis2
ASTEPRO 0.15% has no generic equivalent
Contains 50% higher concentration per spray than azelastine HCl 0.1%
ASTEPRO 0.15% provides trial samples that last 3–5 days
* In 2 placebo-controlled SAR studies (N=1143), ASTEPRO 0.15% (2 sprays per nostril) relieved allergic rhinitis symptoms as early as 30 to 45 minutes, and the effect remained durable over the 4-hour assessment period.
Indication for ASTEPRO® 0.15%
ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.
Important Risk Information
- Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
- Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
- In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
- Pregnancy Category C: Based on animal data, may cause fetal harm
Please see full Prescribing Information.
© 2012 Meda Pharmaceuticals Inc. All rights reserved. AST-12-0004